CME 3

 
09.00-12.15    HALL B
   

Eureca-m    

 
EURECA-m Working Group (EUropean REnal and CArdiovascular Medicine)
    

A preview of the future in cardiovascular risk management in CKD

  

Uremic toxins, genetics and systemic disorders at the kidney-cardiovascular system interface

Future pathways to decrease concentration of cardiotoxic uremic toxins
Raymond Vanholder, Ghent, Belgium
Genetic epidemiology of the cardio-renal risk linked to urate transporters
Francesca Mallamaci, Reggio Calabria, Italy
Hypertension in systemic diseases
Andrzej J. Wiecek, Katowice, Poland

Decreasing adverse cardiac outcomes in CKD

Renal congestion in heart failure: concept and impact on outcome
Mehmet Kanbay, Istanbul, Turkey
Novel therapeutic approaches to heart failure in CKD patients
Patrick Rossignol, Vandoeuvre-Les-Nancy, France
How to prevent sudden death in chronic kidney disease
Gunnar Heine, Homburg/Saar, Germany

- See more at: http://www.era-edta2016.org/en-US/preliminary-scientific-programme#sthash.ORt5X61E.dpuf

Uremic toxins, genetics and systemic disorders at the kidney-cardiovascular system interface

Future pathways to decrease concentration of cardiotoxic uremic toxins
Raymond Vanholder, Ghent, Belgium
Genetic epidemiology of the cardio-renal risk linked to urate transporters
Francesca Mallamaci, Reggio Calabria, Italy
Hypertension in systemic diseases
Andrzej J. Wiecek, Katowice, Poland

Decreasing adverse cardiac outcomes in CKD

Renal congestion in heart failure: concept and impact on outcome
Mehmet Kanbay, Istanbul, Turkey
Novel therapeutic approaches to heart failure in CKD patients
Patrick Rossignol, Vandoeuvre-Les-Nancy, France
How to prevent sudden death in chronic kidney disease
Gunnar Heine, Homburg/Saar, Germany

- See more at: http://www.era-edta2016.org/en-US/preliminary-scientific-programme#sthash.ORt5X61E.dpuf

A preview of the future in cardiovascular risk management in CKD

Uremic toxins, genetics and systemic disorders at the kidney-cardiovascular system interface

Future pathways to decrease concentration of cardiotoxic uremic toxins
Raymond Vanholder, Ghent, Belgium
Genetic epidemiology of the cardio-renal risk linked to urate transporters
Francesca Mallamaci, Reggio Calabria, Italy
Hypertension in systemic diseases
Andrzej J. Wiecek, Katowice, Poland

Decreasing adverse cardiac outcomes in CKD

Renal congestion in heart failure: concept and impact on outcome
Mehmet Kanbay, Istanbul, Turkey
Novel therapeutic approaches to heart failure in CKD patients
Patrick Rossignol, Vandoeuvre-Les-Nancy, France
How to prevent sudden death in chronic kidney disease
Gunnar Heine, Homburg/Saar, Germany

- See more at: http://www.era-edta2016.org/en-US/preliminary-scientific-programme#sthash.ORt5X61E.dpuf

A preview of the future in cardiovascular risk management in CKD

Uremic toxins, genetics and systemic disorders at the kidney-cardiovascular system interface

Future pathways to decrease concentration of cardiotoxic uremic toxins
Raymond Vanholder, Ghent, Belgium
Genetic epidemiology of the cardio-renal risk linked to urate transporters
Francesca Mallamaci, Reggio Calabria, Italy
Hypertension in systemic diseases
Andrzej J. Wiecek, Katowice, Poland

Decreasing adverse cardiac outcomes in CKD

Renal congestion in heart failure: concept and impact on outcome
Mehmet Kanbay, Istanbul, Turkey
Novel therapeutic approaches to heart failure in CKD patients
Patrick Rossignol, Vandoeuvre-Les-Nancy, France
How to prevent sudden death in chronic kidney disease
Gunnar Heine, Homburg/Saar, Germany

- See more at: http://www.era-edta2016.org/en-US/preliminary-scientific-programme#sthash.ORt5X61E.dpuf

Part I

Uremic toxins, genetics and systemic disorders at the kidney-cardiovascular system interface

Chairs: Gérard London, Paris, France
             Alberto Ortiz, Madrid, Spain

Future pathways to decrease concentration of cardiotoxic uremic toxins
Raymond Vanholder, Ghent, Belgium
Genetic epidemiology of the cardio-renal risk linked to urate transporters
Francesca Mallamaci, Reggio Calabria, Italy
Hypertension in systemic diseases
Andrzej Więcek, Katowice, Poland

Part II

Decreasing adverse cardiac outcomes in CKD

Chairs: Charles Ferro, Birmingham, United Kingdom
            Carmine Zoccali, Reggio Calabria, Italy

Renal congestion in heart failure: concept and impact on outcome
Mehmet Kanbay, Istanbul, Turkey
Novel therapeutic approaches to heart failure in CKD patients
Patrick Rossignol, Nancy, France
How to prevent sudden death in chronic kidney disease
Gunnar Heine, Homburg/Saar, Germany
 

CME Courses on May 21, 2016 are reserved to regularly registered congress members and are included in the registration fee. In order to participate in the CME Courses, all regularly registered congress members must go to the session halls and have their badge scanned by the hostesses at the entrance (at participant’s own responsibility). Please note that the seat capacity of the conference rooms is limited, therefore participation in these courses will be on a “first come first served” basis.

  
back to the timetable

final programme "day by day" - may 21 - 24, 2016

today